VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development

Welcome to VacciTalks by Alira Health – exclusive educational appointments with the leading vaccine experts.

Multimedia
Category:
Published on:
May 10, 2022

For private companies, vaccine development is difficult, risky and takes time and money. Only a few candidates will reach the market and will help to protect patients. Companies are in severe competition to develop and bring their final vaccine products into the supply chain. In the second episode of VacciTalks, together with vaccine expert Roberto Camerini we peeked behind the scenes of vaccine development and get a unique insider look at vaccine development. We discussed difficulties, hurdles, and bottlenecks that vaccine produces face during the vaccine development and even after the product is delivered to the market and ways to overcome them.

During this VacciTalk you can learn:

  • How to set up a pipeline for a vaccine candidate
  • How to navigate process difficulties and prevent bottlenecks
  • Why partners, support, collaboration, and funding are essential
  • Market outlook and prospects for newly developed vaccines

In the course of his career, Roberto has held important management roles in Research and Development for international pharmaceutical groups (Abbott, Serono, Sigma-tau, Alfa-Wassermann, Alfasigma, Cosmo) where he was involved in the development and registration of new molecules and biological products in different therapeutic areas.

He served as Board Director of Sciclone Pharmaceutical Inc. and he is also co-founder and member of the board of directors of the Nibit Foundation (Italian Network for the Biotherapy of Tumors).

Roberto graduated cum laude in Medicine and Surgery at University of Rome “La Sapienza” and specialized with full marks in Liver and Metabolic Diseases at the same University.

Roberto is currently the Medical Director of ReiThera Srl.

Our hosts 

Bernd Schollmeier, Vice President, Global Market Access Vaccines 
Bernd Schollmeier

A vaccine expert with more than 30 years of experience, Bernd has been responsible for a range of global pricing and market access initiatives for vaccines in the international pharmaceutical companies — from delivering a range of solutions across development and strategic market access considerations for trial design to value demonstration in P&R negotiations as well as commercialization strategies.

 

Kenny Carberry, Associate Director, Clinical Development 
Kenny Carberry

Kenny’s background covers a wide array of indications across pharma, medical devices, and digital health. He has multiple years of experience in clinical trial operations and management and offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

 

About VacciTalks

VacciTalks is a series of unique appointments with the Key Opinion Leaders of the vaccine world. During each of the episodes, our hosts Bernd Schollmeier and Kenny Carberry will sit down with their guests and talk about the topics that disrupt the vaccine world right now – from development challenges to COVID-19 impact, new technologies, and much more.  

Follow us on LinkedIn and never miss the next VacciTalk!  

Related news

News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
News September 6, 2022
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Biotech Market Access Pharma Therapeutics
Multimedia July 20, 2022
The Promise and Reality of NGTs
Listen to the episode “The Promise and Reality of Next Generation Therapies".
Market Access
Events June 30, 2022
DTx France 2022
We are pleased to announce that we will be joining as speakers and exhibitors at DTx France 2022. This hybrid event will focus on the latest DTx trends, regulatory framework, market(...)
DTx trends Market Access Regulatory
Multimedia June 21, 2022
Increasing Access to Genomic Testing in Europe
Listen to the episode “Increasing Access to Genomic Testing in Europe: The role of national genomic initiatives in increasing uptake of Advanced Diagnostics”.
Genomic Testing Market Access MedTech
Multimedia May 10, 2022
VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development
Join the 2nd episode of VacciTalks where together with vaccine expert Roberto Camerini we will peek behind the scenes of vaccine development and get an insider look at the difficulties,(...)
Market Access
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.